Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
Clinical trial update describing a follow-up protocol for individuals previously enrolled in CAR-T cell studies, detailing a gene therapy fo…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma [NA]
This clinical trial update describes ongoing recruitment for a non-chemotherapeutic intervention study intended to improve quality of life a…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Universal CAR-T Cell Therapy for MM [NA]
A clinical trial is recruiting for a universal CAR-T cell therapy to treat multiple myeloma, including relapsed and refractory disease. The …
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Collection of Samples and Clinical Data From Patients With Amyloid Diseases
This clinical trial update notes ongoing recruitment to collect samples and clinical data from patients with amyloid diseases, including tho…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma [Phase 1]
Phase 1 study evaluating belantamab mafodotin plus standard of care in newly diagnosed multiple myeloma. The trial is currently ACTIVE_NOT_R…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating isatuximab, dexamethasone, and lenalidomide in ultra-frail patients with multiple myeloma and plasma cell leukemia,…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Mozobil for Autologous Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial update for Mozobil (plerixafor) in autologous hematopoietic stem cell transplantation, enrolling patients with multip…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients [NA]
This is a clinical trial update describing a resistance physical exercise program for patients with multiple myeloma; the study is currently…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration [Phase 1]
A Phase 1 clinical trial evaluating dual-target BCMA-CD19 CAR-T cell therapy for relapsed or refractory multiple myeloma with extramedullary…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
This clinical trial entry outlines PROMISE, a study aimed at predicting progression to multiple myeloma in a high-risk screened population. …
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Allogeneic UCB-derived, Dual-targeting BCMA/CD19 CAR-T for Relapsed/Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating an allogeneic umbilical cord blood–derived dual-targeting BCMA/CD19 CAR-T therapy for relapsed/refractory …
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating a dual-target CAR-T therapy (CAR19-BCMA) for relapsed/refractory multiple myeloma is currently re…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients
A completed non-interventional study assessing Kyprolis in combination with Revlimid and dexamethasone, or dexamethasone alone, or with Darz…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma [Phase 2]
This clinical trial update outlines the Phase 2 ELDORADO study, comparing Elranatamab versus Daratumumab each in combination with RVd Lite, …
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).
Pfizer is conducting a Korean post-marketing surveillance study of ELREXFIO (elranatamab) in adults with multiple myeloma to monitor safety …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: e-Motion : Promoting Emotion Regulation in Chronic Cancer [NA]
A clinical trial update for e-Motion, an emotion regulation program, being studied in patients with metastatic cancer and multiple myeloma; …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies [Phase 1]
A Phase 1 clinical trial of an in vivo CAR-T therapy for relapsed/refractory hematologic cancers is currently recruiting. The study targets …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A New Study Evaluating the Activity of Modular CAR T for mYeloma [Phase 1]
A Phase 1 study at University College London is evaluating the activity of Modular CAR T therapy in patients with multiple myeloma and is cu…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Registry for Adults With Plasma Cell Disorders (PCD's)
Clinical trial registry update for adults with plasma cell disorders indicating active recruitment. The study is sponsored by UNC Lineberger…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients [Phase 2]
Phase 2 study evaluating post-transplant maintenance therapy with isatuximab plus lenalidomide for high-risk multiple myeloma; currently rec…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
Ongoing recruitment for studies evaluating novel treatments to improve renal outcomes in light-chain cast nephropathy, including patients wi…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
This clinical trial update reports ongoing recruitment for a study examining how quantitative and qualitative monocyte characteristics influ…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma [Phase 2]
This report summarizes a Phase 2 clinical trial evaluating outpatient and intermittent dosing of elranatamab for relapsed/refractory multipl…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial [Phase 1, Phase 2]
The AMBUSH trial is a Phase 1/2 study evaluating Bortezomib and Pembrolizumab with or without Pelareorep for relapsed or refractory multiple…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS) [NA]
A clinical trial is evaluating a plant-based diet and dietary supplements in people with smoldering multiple myeloma or monoclonal gammopath…